SS
PRPH

SBI Securities’s ProPhase Labs PRPH Stock Holding History

SBI Securities’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50
Closed -$22 – 4124
2025
Q4 		$22 Hold
50
– – ﹤0.01% 3762
2025
Q3 		$231 Hold
50
– – ﹤0.01% 3268
2025
Q2 		$197 Buy
50
+10
+25% +$33 ﹤0.01% 3311
2025
Q1 		$163 Hold
40
– – ﹤0.01% 3291
2024
Q4 		$306 Buy
+40
New +$561 ﹤0.01% 3078

Other funds holding PRPH

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SBI Securities's PRPH Position: Q1 2026 in Review

SBI Securities sold out of ProPhase Labs (PRPH) in Q1 2026, closing a stake of 50 shares — an estimated $22 sold.

SBI Securities first reported a position in PRPH in Q4 2024 and held it in 5 quarters. The position peaked at $306 in Q4 2024. 2 funds tracked by Wall St. Rank hold PRPH as of Q1 2026.

  • SBI Securities reported no remaining ProPhase Labs position as of Q1 2026 after selling out during the quarter.
  • SBI Securities sold 50 ProPhase Labs shares in Q1 2026, an estimated $22.
  • SBI Securities first reported a position in ProPhase Labs in Q4 2024 and held it in 5 quarters.
  • SBI Securities's ProPhase Labs position peaked at $306 in Q4 2024.
  • 2 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.